Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Venous Disease: Features

Letter to the Editor
What’s in a Name? A TIPS Conundrum
01/11/2024
The authors suggest new terminology for transjugular intrahepatic portosystemic shunt (TIPS) that better reflects the image guidance and intrahepatic tract.
The authors suggest new terminology for transjugular intrahepatic portosystemic shunt (TIPS) that better reflects the image guidance and intrahepatic tract.
The authors suggest new...
01/11/2024
Vascular Disease Management
Review
The VenaSeal Procedure: Review of an Advanced Treatment Modality for Varicose Veins
12/19/2023
The authors provide an overview of cyanoacrylate adhesive and the preclinical and clinical studies conducted to date to prove the efficacy, detailed procedure, advantages, complications, and limitations of VenaSeal procedure.
The authors provide an overview of cyanoacrylate adhesive and the preclinical and clinical studies conducted to date to prove the efficacy, detailed procedure, advantages, complications, and limitations of VenaSeal procedure.
The authors provide an overview...
12/19/2023
Vascular Disease Management
Case Report
Iatrogenic Arteriovenous Fistula Between the Radial Artery and Cephalic Vein
11/03/2023
This is a unique case of a 15-month-old female infant who presented with a pulsatile mass on the right wrist. An arteriogram showed a communication between the radial artery and cephalic vein.
This is a unique case of a 15-month-old female infant who presented with a pulsatile mass on the right wrist. An arteriogram showed a communication between the radial artery and cephalic vein.
This is a unique case of a...
11/03/2023
Vascular Disease Management
Case Report
Safety and Efficacy of Periorbital Sclerotherapy
11/01/2023
This case demonstrates that although there is hesitancy to use sclerotherapy for the management of reticular veins due to neurologic and ophthalmic complications, sclerotherapy can be a minimally invasive treatment option.
This case demonstrates that although there is hesitancy to use sclerotherapy for the management of reticular veins due to neurologic and ophthalmic complications, sclerotherapy can be a minimally invasive treatment option.
This case demonstrates that...
11/01/2023
Vascular Disease Management
Original Research
Mechanical and Pharmacological Treatment of Symptomatic Acute Portomesenteric Venous Thrombosis Through a TIPS Tract
10/30/2023
The authors evaluate the technical feasibility, long-term patency rate, and clinical outcome in patients who presented with symptomatic acute portomesenteric thrombosis and were treated with mechanical thrombectomy and pharmacological...
The authors evaluate the technical feasibility, long-term patency rate, and clinical outcome in patients who presented with symptomatic acute portomesenteric thrombosis and were treated with mechanical thrombectomy and pharmacological...
The authors evaluate the...
10/30/2023
Vascular Disease Management
Interview
When Is the VenaSeal Closure System Appropriate for Patients With Ulcers and Combined Arterial and Venous Disease?
10/30/2023
Michael Shao, MD, RVPI, discusses his presentation at AMP 2023 about the VenaSeal closure system and when it is appropriate for use in combined arterial and venous disease.
Michael Shao, MD, RVPI, discusses his presentation at AMP 2023 about the VenaSeal closure system and when it is appropriate for use in combined arterial and venous disease.
Michael Shao, MD, RVPI,...
10/30/2023
Vascular Disease Management
Dr N'Dandu
AMP 2023
Latest Results of the PROMISE II US Pivotal Trial of the LimFlow System
10/04/2023
In this video recorded at AMP 2023, interventional cardiologist Zola N'Dandu, MD, discusses his presentation on the latest results of the PROMISE II U.S. Pivotal Trial, which investigated the safety and effectiveness of the LimFlow System.
In this video recorded at AMP 2023, interventional cardiologist Zola N'Dandu, MD, discusses his presentation on the latest results of the PROMISE II U.S. Pivotal Trial, which investigated the safety and effectiveness of the LimFlow System.
In this video recorded at AMP...
10/04/2023
Vascular Disease Management
Case Report With Review
Iatrogenic Radial Arteriovenous Fistula After Coronary Angiography
08/24/2023
The authors review the management of radial AVF and describe a case of an otherwise healthy man who developed a radial AVF after coronary angiography.
The authors review the management of radial AVF and describe a case of an otherwise healthy man who developed a radial AVF after coronary angiography.
The authors review the...
08/24/2023
Vascular Disease Management
Venclose RF Ablation Catheter
Video
Choose RF Ablation Using the Venclose™ RF Ablation Catheter Featuring Dual Heating Lengths
06/26/2023
Watch this video on the Venclose™ RF Ablation Catheter.
Watch this video on the Venclose™ RF Ablation Catheter.
Watch this video on the...
06/26/2023
Vascular Disease Management
Interview
Treating Chronic Venous Disease With the Venclose Maven™ Perforator Catheter
06/19/2023
VDM spoke with Dr Nathan Tomita about treating patients with chronic venous disease and how the Venclose Maven Perforator Catheter (BD) has given him a modernized, 360° RF solution to treat patients with incompetent perforator veins.
VDM spoke with Dr Nathan Tomita about treating patients with chronic venous disease and how the Venclose Maven Perforator Catheter (BD) has given him a modernized, 360° RF solution to treat patients with incompetent perforator veins.
VDM spoke with Dr Nathan Tomita...
06/19/2023
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement